Root-end surgery with leucocyte- and platelet-rich fibrin and an occlusive membrane: a randomized controlled clinical trial on patients' quality of life.
Nastaran MeschiSteffen FieuwsAnke VanhoenackerOlaf StrijbosDominique Van der VekenConstantinus PolitisPaul LambrechtsPublished in: Clinical oral investigations (2018)
Although LPRF seems to be an inexpensive and autologous agent to reduce pain and swelling post RES, this RCT does not provide a statistical significant evidence for that.
Keyphrases
- end stage renal disease
- ejection fraction
- newly diagnosed
- chronic kidney disease
- minimally invasive
- chronic pain
- bone marrow
- coronary artery bypass
- neuropathic pain
- pain management
- cell therapy
- coronary artery disease
- platelet rich plasma
- atrial fibrillation
- mesenchymal stem cells
- patient reported outcomes
- sickle cell disease
- spinal cord
- patient reported